Home Capital Broker's Calls

Insurance co-pay seen to have little near-term impact on Raffles Medical

PC Lee
PC Lee3/13/2018 11:12 AM GMT+08  • 2 min read
Insurance co-pay seen to have little near-term impact on Raffles Medical
SINGAPORE (Mar 13): UOB KayHian is maintaining Raffles Medical Group at "buy" given it sees limited impact on the stock from changes in insurance co-pay terms for new policies.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Mar 13): UOB KayHian is maintaining Raffles Medical Group at "buy" given it sees limited impact on the stock from changes in insurance co-pay terms for new policies.

With immediate effect, new insurance policies with riders or existing policyholders buying a new rider will need to eventually pay at least 5% of his hospital bill. However, the amount the policyholder needs to pay can be capped at $3,000/year although insurers can set a higher threshold. The $3,000 cap would only apply if patients are treated by doctors on the insurers’ panel.

UOB says there would be limited impact on Raffles Medical as its practice model allows doctors to focus on patients' health rather than profitability. There is also medical fee transparency for its treatment. More importantly, all in-patient treatment and operations are subject to a peer review by a panel of medical doctors.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now